878101P

C17 Lyso PAF

Avanti Research^™ - A Croda Brand 878101P, powder

• Sinónimos: 1-O-heptadecyl-2-hydroxy-sn-glycero-3-phosphocholine
• Fórmula empírica (notación de Hill): C₂₅H₅₄NO₆P
• Número de CAS: 111858-52-7
• Peso molecular: 495.67
• UNSPSC Code: 12352211
• NACRES: NA.25

Propiedades

• form: powder
• packaging: pkg of 1 × 10 mg (878101P-10mg)
• manufacturer/tradename: Avanti Research^™ - A Croda Brand 878101P
• lipid type: bioactive lipids; phosphoglycerides
• shipped in: dry ice
• storage temp.: −20°C
• SMILES string: O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COCCCCCCCCCCCCCCCCC

Descripción

General description

C17 Lyso PAF, also known as 1-O-heptadecyl-2-hydroxy-sn-glycero-3-phosphocholine, is a precursor and metabolite of 1-O-heptadecyl-2-acetyl-sn-glycero-3-phosphocholine (C17:0 PAF). Lyso-platelet activating factor (PAF) is synthesized from PAF acetylhydrolases by the degradation of PAF. It is also synthesized from 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine (1-alkyl-phosphatidylcholine; PC) by the enzyme phospholipase A2 via the remodeling pathway.

Packaging

5 mL Amber Glass Screw Cap Vial (878101P-10mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Información de seguridad

• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 3